Search

Bringing the eye's "donut of drainage," aka trabecular meshwork and Schlemm’s canal models of glaucoma up to date with technology

An inside view on the San Diego company working to bring drug delivering contact lenses to market.

Can we repair the visual and cognitive damage caused by long COVID?

How AI-enabled tools can democratize cell painting to speed up drug discovery and reduce failure rates

A peek into the life of a parasite infecting a host cell

Find out how nanotechnology can overcome challenges in drug delivery to the eye

Clinical trials suffer from heavy dropout rates. Perhaps the answer is a little care and attention.

Disease research should embrace the biotechnology available to increase drug development success

What have glaucoma researchers Ningli Wang – in China – and Ted Garway-Heath – in the UK – been busy with?

The war in Ukraine has massively impacted clinical trials. We spoke to one man tracking the disruption.